Kale Amit A, Torchilin Vladimir P
Department of Pharmaceutical Sciences, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA, USA.
Methods Mol Biol. 2010;605:213-42. doi: 10.1007/978-1-60327-360-2_15.
Liposomal nanocarriers anchored with a cell-penetrating peptide and a pH-sensitive PEG-shield where later has ability to provide simultaneously better systemic circulation and site-specific exposure of cell penetrating peptide. PEG chains were incorporated into the liposome membrane via the PEG-attached phosphatidylethanolamine (PE) residue with PEG and PE being conjugated with the lowered pH-degradable hydrazone bond (PEG-HZ-PE), while cell-penetrating peptide (TATp) was added as TATp-PEG-PE conjugate. Under normal conditions, liposome-grafted PEG "shielded" liposome-attached TATp moieties, since the PEG spacer for TATp attachment (PEG(1000)) was shorter than protective PEG(2000). PEGylated liposomes accumulate in targets via the EPR effect, but inside the "acidified" tumor or ischemic tissues lose their PEG coating because of the lowered pH-induced hydrolysis of HZ and penetrate inside cells via the now-exposed TATp moieties. pH-responsive behavior of these constructs is successfully tested in cell cultures in vitro as well as in tumors in experimental mice in vivo. These nanocarriers also showed enhanced pGFP transfection efficiency upon intratumoral administration in mice, compared to control pH nonsensitive counterpart. These results can be considered as an important step in the development of tumor-specific stimuli-sensitive drug and gene delivery systems.
脂质体纳米载体锚定有细胞穿透肽和pH敏感的聚乙二醇(PEG)屏蔽层,后者能够同时实现更好的全身循环以及细胞穿透肽的位点特异性暴露。PEG链通过与PEG连接的磷脂酰乙醇胺(PE)残基掺入脂质体膜中,PEG和PE通过可在较低pH值下降解的腙键(PEG-HZ-PE)共轭,而细胞穿透肽(TATp)以TATp-PEG-PE共轭物的形式添加。在正常条件下,脂质体嫁接的PEG“屏蔽”了脂质体附着的TATp部分,因为用于连接TATp的PEG间隔基(PEG(1000))比保护性PEG(2000)短。聚乙二醇化脂质体通过增强渗透滞留(EPR)效应在靶标中积累,但在“酸化”的肿瘤或缺血组织内部,由于HZ在较低pH值下诱导水解,它们会失去PEG涂层,并通过现在暴露的TATp部分穿透进入细胞。这些构建体的pH响应行为在体外细胞培养以及实验小鼠体内的肿瘤中均得到成功测试。与对照pH不敏感的对应物相比,这些纳米载体在小鼠瘤内给药后还显示出增强的绿色荧光蛋白(pGFP)转染效率。这些结果可被视为肿瘤特异性刺激敏感型药物和基因递送系统开发中的重要一步。